-
Fisetin, Ferroptosis, and Neuroprotection After TBI
2026-09-01
Yang et al. show that fisetin reduces neurological injury, oxidative stress, and ferroptosis-associated changes in mouse and cell models of traumatic brain injury, with PI3K/AKT/NRF2 signaling implicated in the response. The study supports a multi-readout strategy for examining ferroptosis after TBI while highlighting the need to distinguish pharmacological pathway modulation from definitive causal proof.
-
BIRC2 and BIRC3 Regulation in Pulmonary Epithelium
2026-09-01
Thorne et al. distinguish the cytokine- and glucocorticoid-dependent regulation of BIRC2 and BIRC3 in pulmonary epithelial models, showing that BIRC3 is strongly inducible whereas BIRC2 remains comparatively constitutive. The findings clarify how inflammatory and corticosteroid signals may coordinate epithelial survival and NF-κB-associated responses across submerged and air–liquid interface cultures.
-
Tamsulosin: Bench Workflows for Urological Research
2026-08-31
Tamsulosin links selective α₁A-adrenergic receptor antagonism with practical models of ureteral passage, bladder-neck relaxation, and postoperative urinary retention. This guide translates clinical evidence into reproducible assay setup, dosing-screen logic, solubility control, and troubleshooting decisions for translational researchers.
-
SAG as a Hedgehog Pathway Assay Control
2026-08-31
SAG is a Smoothened receptor agonist that can separate ligand-level Hedgehog biology from downstream pathway competence. This article develops an assay-centered framework for interpreting SAG responses across neural, developmental, stem cell, immune, and tumorigenesis research.
-
Native PAGE and VHL-Deficient Cancer Biology
2026-08-30
A translational perspective on how native protein gel electrophoresis can extend the mechanistic study of Dinaciclib sensitivity in VHL-deficient clear cell renal cell carcinoma. The article connects therapeutic phenotype, intact protein states, and practical workflow design using the Basic Protein Native PAGE Gel Preparation and Electrophoresis Kit (PI ≤ 7.0).
-
Gallein: Mapping Gβγ Control Across GPCR Models
2026-08-29
Gallein is a G protein βγ subunit inhibitor for dissecting GPCR signaling in cancer, immune, cardiac, and metabolic models. This article connects its established in vivo evidence with the lactate–GPR81/FARP1 pathway while defining practical assay boundaries and interpretation strategies.
-
YM 58483 (BTP2) for SOCE Workflows
2026-08-28
YM 58483 (BTP2) provides a practical way to interrupt sustained store-operated calcium entry in immune-cell activation and radiation-associated fibrosis models. This guide connects calcium-flux measurements with NFAT, IL-2, ORAI2, and TGF-β1 readouts while emphasizing controls and troubleshooting.
-
Diphenyleneiodonium chloride: Redox Assay Workflows
2026-08-28
Diphenyleneiodonium chloride, or DPI, is a versatile probe for separating flavoprotein-dependent oxidative signaling from GPR3-driven cAMP responses. This practical guide translates a citrus canker resistance study into controlled redox, ROS, cell-death, and cAMP workflows, with concentration planning and troubleshooting guidance.
-
RG108: DNA Methyltransferase Inhibitor Guide
2026-08-27
RG108 is a small-molecule DNA methyltransferase inhibitor for experimental epigenetic gene regulation modulation. Its reported 600 nM IC50 in the M.SssI assay supports enzymatic DNMT inhibition, while its non-trapping profile makes it useful for DNA demethylation and tumor suppressor gene reactivation studies.
-
Thermal Shift Assay for Bacterial Sensor Ligands
2026-08-27
The 2025 FEMS Microbiology Reviews article examines how thermal shift assays can reveal ligand recognition by bacterial receptors, solute-binding proteins, and transcriptional regulators. Its main practical contribution is a balanced workflow that combines soluble ligand-binding domains, pH optimization, careful interpretation of thermal shifts, and orthogonal confirmation such as isothermal titration calorimetry.
-
IPR-803: Small-Molecule uPAR Inhibition in Metastasis
2026-08-26
The reference study established compound 4, identified here as IPR-803, as a small-molecule disruptor of the urokinase receptor–urokinase-type plasminogen activator interaction. By combining direct-binding assays, cellular invasion models, pharmacokinetics, and a breast cancer metastasis model, the authors connected molecular PPI inhibition with reduced metastatic burden and defined a starting point for further uPAR inhibitor optimization.
-
Phosbind Acrylamide: Reading Phosphorylation States
2026-08-26
Phosbind Acrylamide enables antibody-free protein phosphorylation analysis by converting phosphate-dependent molecular differences into resolvable SDS-PAGE mobility shifts. This guide focuses on how to interpret those shifts mechanistically, using lessons from MCM8-9 helicase reconstitution to improve assay design and experimental controls.
-
Eicosapentaenoic Acid: Designing Better Assays
2026-08-25
Eicosapentaenoic Acid (EPA) is more than an omega-3 ingredient: it is a concentration-sensitive membrane and lipid-oxidation perturbation tool. This guide connects EPA assay design with emerging lipid-mediated immunology while defining the evidence boundaries for cardiovascular disease research.
-
Meropenem Workflows for Resistance Research
2026-08-25
Build reproducible Meropenem assays for susceptibility testing, time-kill analysis, resistance selection, and Gram-negative infection models. This guide separates evidence-backed product specifications from practical starting conditions and shows how exposure-focused designs can improve translational value.
-
GSK126 EZH2 Inhibitor: Assay Guide
2026-08-24
A scenario-based guide to using GSK126 EZH2 inhibitor (SKU A3446) in viability, proliferation, and cytotoxicity workflows. It connects EZH2 biology with practical dosing, solubility, controls, interpretation, and vendor-selection decisions for reproducible cancer epigenetics research.